208 related articles for article (PubMed ID: 10768944)
21. Protection against Helicobacter pylori infection by a trivalent fusion vaccine based on a fragment of urease B-UreB414.
Wang L; Liu XF; Yun S; Yuan XP; Mao XH; Wu C; Zhang WJ; Liu KY; Guo G; Lu DS; Tong WD; Wen AD; Zou QM
J Microbiol; 2010 Apr; 48(2):223-8. PubMed ID: 20437155
[TBL] [Abstract][Full Text] [Related]
22. Poliovirus replicons encoding the B subunit of Helicobacter pylori urease protect mice against H. pylori infection.
Smythies LE; Novak MJ; Waites KB; Lindsey JR; Morrow CD; Smith PD
Vaccine; 2005 Jan; 23(7):901-9. PubMed ID: 15603891
[TBL] [Abstract][Full Text] [Related]
23. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis.
Lee CK; Weltzin R; Thomas WD; Kleanthous H; Ermak TH; Soman G; Hill JE; Ackerman SK; Monath TP
J Infect Dis; 1995 Jul; 172(1):161-72. PubMed ID: 7797906
[TBL] [Abstract][Full Text] [Related]
24. Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis.
Corthésy B; Boris S; Isler P; Grangette C; Mercenier A
J Infect Dis; 2005 Oct; 192(8):1441-9. PubMed ID: 16170763
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori.
Xing Y; Liu W; Li X; Guo L; Lv X; Xi T
Biochem Biophys Res Commun; 2015 Jul; 462(3):269-74. PubMed ID: 25957472
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic efficacy of oral immunization with a non-genetically modified Lactococcus lactis-based vaccine CUE-GEM induces local immunity against Helicobacter pylori infection.
Liu W; Tan Z; Xue J; Luo W; Song H; Lv X; Zheng T; Xi T; Xing Y
Appl Microbiol Biotechnol; 2016 Jul; 100(14):6219-6229. PubMed ID: 26846746
[TBL] [Abstract][Full Text] [Related]
27. Oral immunization with recombinant Helicobacter pylori urease confers long-lasting immunity against Helicobacter felis infection.
Myers GA; Ermak TH; Georgakopoulos K; Tibbitts T; Ingrassia J; Gray H; Kleanthous H; Lee CK; Monath TP
Vaccine; 1999 Mar; 17(11-12):1394-403. PubMed ID: 10195775
[TBL] [Abstract][Full Text] [Related]
28. Immunologic properties and therapeutic efficacy of a multivalent epitope-based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils.
Guo L; Yin R; Xu G; Gong X; Chang Z; Hong D; Liu H; Ding S; Han X; Li Y; Tang F; Liu K
Helicobacter; 2017 Dec; 22(6):. PubMed ID: 28851031
[TBL] [Abstract][Full Text] [Related]
29. Immunogenicity of oral vaccination with Lactococcus lactis derived vaccine candidate antigen (UreB) of Helicobacter pylori fused with the human interleukin 2 as adjuvant.
Zhang HX; Qiu YY; Zhao YH; Liu XT; Liu M; Yu AL
Mol Cell Probes; 2014 Feb; 28(1):25-30. PubMed ID: 24036137
[TBL] [Abstract][Full Text] [Related]
30. A novel chimeric flagellum fused with the multi-epitope vaccine CTB-UE prevents Helicobacter pylori-induced gastric cancer in a BALB/c mouse model.
Song H; Lv X; Yang J; Liu W; Yang H; Xi T; Xing Y
Appl Microbiol Biotechnol; 2015 Nov; 99(22):9495-502. PubMed ID: 26062531
[TBL] [Abstract][Full Text] [Related]
31. Oral vaccination of mice against Helicobacter pylori with recombinant Lactococcus lactis expressing urease subunit B.
Gu Q; Song D; Zhu M
FEMS Immunol Med Microbiol; 2009 Aug; 56(3):197-203. PubMed ID: 19453750
[TBL] [Abstract][Full Text] [Related]
32. Development and evaluation of a DNA vaccine based on Helicobacter pylori urease B: failure to prevent experimental infection in the mouse model.
Zavala-Spinetti L; Breslin MB; Correa H; Bégué RE
Helicobacter; 2006 Dec; 11(6):517-22. PubMed ID: 17083372
[TBL] [Abstract][Full Text] [Related]
33. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers.
Metzger WG; Mansouri E; Kronawitter M; Diescher S; Soerensen M; Hurwitz R; Bumann D; Aebischer T; Von Specht BU; Meyer TF
Vaccine; 2004 Jun; 22(17-18):2273-7. PubMed ID: 15149786
[TBL] [Abstract][Full Text] [Related]
34. Oral immunization of mice with a multivalent therapeutic subunit vaccine protects against Helicobacter pylori infection.
Liu M; Zhong Y; Chen J; Liu Y; Tang C; Wang X; Zhang Y; Wang P; Logan SM; Chen W; Wei B
Vaccine; 2020 Mar; 38(14):3031-3041. PubMed ID: 32139315
[TBL] [Abstract][Full Text] [Related]
35. Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines.
Aebischer T; Bumann D; Epple HJ; Metzger W; Schneider T; Cherepnev G; Walduck AK; Kunkel D; Moos V; Loddenkemper C; Jiadze I; Panasyuk M; Stolte M; Graham DY; Zeitz M; Meyer TF
Gut; 2008 Aug; 57(8):1065-72. PubMed ID: 18417532
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic vaccination against Helicobacter pylori infection with attenuated recombinant Salmonella typhimurium urease B subunit and catalase in mice.
Li GQ; Chen MH; Zhu SL; Chen J; Jiao ZY; Chen W; Hu PJ
Chin J Dig Dis; 2004; 5(2):72-5. PubMed ID: 15612661
[TBL] [Abstract][Full Text] [Related]
37. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults.
Michetti P; Kreiss C; Kotloff KL; Porta N; Blanco JL; Bachmann D; Herranz M; Saldinger PF; Corthésy-Theulaz I; Losonsky G; Nichols R; Simon J; Stolte M; Ackerman S; Monath TP; Blum AL
Gastroenterology; 1999 Apr; 116(4):804-12. PubMed ID: 10092302
[TBL] [Abstract][Full Text] [Related]
38. Oral vaccination with liposome-encapsulated recombinant fusion peptide of urease B epitope and cholera toxin B subunit affords prophylactic and therapeutic effects against H. pylori infection in BALB/c mice.
Zhao W; Wu W; Xu X
Vaccine; 2007 Nov; 25(44):7664-73. PubMed ID: 17913305
[TBL] [Abstract][Full Text] [Related]
39. [Immunization with catalase and UreB two-valence vaccine for preventing Helicobacter pylori infection in mice].
Lin HJ; Yang Q; Li J; Liu Y; Wang QY
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):436-7. PubMed ID: 18359706
[TBL] [Abstract][Full Text] [Related]
40. Augmentation of Helicobacter pylori urease activity by its specific IgG antibody: implications for bacterial colonization enhancement.
Iizumi T; Yamanishi S; Kumagai Y; Nagata K; Kamiya S; Hirota K; Watanabe E; Sakamoto C; Takahashi H
Biomed Res; 2005 Feb; 26(1):35-42. PubMed ID: 15806982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
